The Traderszone Network

Published in TZ Latest News 22 August, 2015 by The TZ Newswire Staff

A $25 Billion Hedge Fund Just Made AbbVie One of Its Biggest Bets

AbbVie Inc. could end up sidestepping lost sales tied to an expiring patent on Humira in 2017.